Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in Maryland, automatically classified by Maddy, our AI policy reader.

Total bills
109
2026 Regular Session
Top supporter
C.T. Wilson
100% support rate
Top opponent
Jason Gallion
0% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in Maryland

Legislators moving healthcare in Maryland
Legislator Party Stance Support rate Decisive votes
C.T. Wilson
C.T. Wilson House · District 28
D
Strong +
100% 34
Ben Kramer
Ben Kramer Senate · District 19
D
Strong +
100% 23
Bill Ferguson
Bill Ferguson Senate · District 46
D
Strong +
100% 23
Carl Jackson
Carl Jackson Senate · District 8
D
Strong +
100% 23
Clarence Lam
Clarence Lam Senate · District 12
D
Strong +
100% 23
Jason Gallion
Jason Gallion Senate · District 35
R
Strong −
0% 23
Jack Bailey
Jack Bailey Senate · District 29
R
Strong −
0% 22
J.B. Jennings
J.B. Jennings Senate · District 7
R
Strong −
4% 23
Johnny Salling
Johnny Salling Senate · District 6
R
Strong −
4% 23
Mary Beth Carozza
Mary Beth Carozza Senate · District 38
R
Strong −
5% 22
Showing 91–100 of 109 bills

All healthcare bills

passed · Maryland · House of Delegates Apr 13, 2026

HB 1426: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

HB 1426 creates a new permit for clinical research pharmacies in Maryland, which are facilities specifically designed to conduct clinical trials. It allows healthcare providers to own these pharmacies under strict conditions, including requiring a licensed pharmacist to be on-site during all operating hours and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations or entities from being classified as "practice of medicine," meaning trial staff no longer need individual medical licenses for their trial-related work. This change aims to streamline clinical research by removing a regulatory barrier that previously required individual licensing for trial staff.
passed both · Maryland · House of Delegates Apr 13, 2026

HB 222: County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act)

HB 222 requires Maryland public schools and colleges to update policies and education programs to address opioid overdoses. It mandates schools to store naloxone, allow authorized staff and students to possess it, and provide liability protection for good-faith use during overdoses. The bill also adds naloxone's life-saving role to K-12 drug prevention curricula (starting in third grade) and requires annual parent notifications about school naloxone policies. Additionally, schools must report overdose incidents requiring naloxone use to the State Department. This affects all public K-12 schools and state-funded colleges.
passed both · Maryland · House of Delegates Apr 13, 2026

HB 417: Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

HB 417 (Public Health - Medetomidine and Xylazine Consumer Protection Act) regulates the sale of veterinary drugs medetomidine and xylazine. It prohibits retailers from selling these products without proof the buyer intends to use them for veterinary, scientific, or institutional purposes, and bans sales to anyone under 21. Retailers must maintain records of sales, including age verification and proof of intended use. Violations carry civil fines up to $6,500 per offense, with penalties deposited into Maryland's Substance Abuse Fund. The bill directly affects pharmacies, veterinary suppliers, and online retailers selling these specific products.
passed · Maryland · House of Delegates Apr 10, 2026

HB 1167: Department of Information Technology - Workgroup on the Medicaid Management Information System Mainframe System Replacement

HB 1167 requires Maryland's Department of Health to replace its outdated Medicaid computer system with a modern, flexible system by 2028. The new system must maintain all current Medicaid functions - including processing medical/dental/pharmacy claims, provider enrollment, and beneficiary inquiries - while meeting federal security and performance standards. The bill mandates integration with existing Medicaid systems by January 2027 and full replacement of the old system by January 2028, subject to federal approval. This change directly affects Medicaid beneficiaries and healthcare providers through more reliable service delivery.
passed both · Maryland · Senate Apr 10, 2026

SB 515: Health Services Cost Review Commission - Health Facilities - Rate Setting

SB 515 requires Maryland's Health Services Cost Review Commission to consider all operational costs incurred by health facilities - including expenses for physicians and other providers without corresponding billing revenue - when setting hospital rates. This affects hospitals and health facilities operating under Maryland's all-payer model, as the Commission must now factor in full costs during rate reviews. The bill amends existing law to mandate that the Commission evaluate facility financial health and certify rates based on complete cost accounting, rather than excluding certain expenses. This change ensures rates more accurately reflect actual facility operations, including costs for professional services that previously weren't fully counted.
passed · Maryland · House of Delegates Apr 9, 2026

HB 1014: Mental Health Law - Danger to the Life or Safety of the Individual or of Others - Definition (Right to Treatment)

HB 1014 defines "danger to the life or safety of the individual or of others" for Maryland's mental health law, directly affecting individuals with mental disorders who might face involuntary admission. It specifies four concrete scenarios that constitute this danger: causing bodily harm, engaging in conduct leading to criminal involvement, inability to meet basic needs (food, shelter, medical care), or substantial deterioration in judgment that impairs treatment decisions. The definition requires a "substantial risk" considering the person's current condition and available history, replacing the prior standard. This change clarifies the legal threshold for involuntary hospitalization and emergency evaluations under Maryland law.
passed · Maryland · House of Delegates Mar 25, 2026

HB 1625: Public Health - Newborn Screening Program - Fees and Core Conditions

This bill updates Maryland's newborn screening program by changing how fees are set and how new tests are added to the screening panel. It requires the Department of Health to charge fees that cover all administrative, laboratory, and follow-up costs rather than setting a specific maximum amount. The bill also establishes a process where an advisory council must review risks, costs, and accessibility before the department decides whether to test for new conditions added to the national screening panel. Additionally, it extends the timeline for implementing new tests to two years if equipment or supplies are delayed, with required reporting to state committees.
passed · Maryland · House of Delegates Mar 24, 2026

HB 860: Petitions for Emergency Evaluation (Arnaud and Magruder Memorial Act)

HB 860, the Arnaud and Magruder Memorial Act, sets a 5-day initial limit for emergency evaluation petitions after court approval, with extensions of up to 5 days each (totaling no more than 30 days) based on the individual's current behavior. The bill requires courts to include the petition's expiration date and clarifies that peace officers must transport individuals to emergency facilities when holding a valid petition (either court-endorsed within 5 days or signed by authorized professionals), allowing electronic petitions. This law directly affects courts reviewing petitions, peace officers executing them, emergency facilities receiving individuals, and people subject to emergency evaluations. It standardizes timelines and procedures to ensure timely care while preventing prolonged detention without court review.
passed · Maryland · House of Delegates Mar 23, 2026

HB 1593: Community Pathways Waiver - Adoption of Regulations

HB 1593 requires Maryland's Deputy Secretary for Developmental Disabilities to provide public notice before changing the Self-Directed Services Manual, which governs waiver program services for individuals with developmental disabilities. The bill mandates a 90-day public comment period for proposed changes and prohibits adopting any revisions until this period ends. It directly affects individuals and families using self-directed services - where participants control their own care choices, staffing, and budget management - and ensures their input is considered before policy changes take effect. This procedural bill amends Maryland’s health code to formalize transparency and public engagement in updating the manual (effective October 1, 2026).
passed · Maryland · House of Delegates Mar 23, 2026

HB 837: Education - Student Athletic Activities - Cardiovascular Prescreening

HB 837 requires all Maryland public and nonpublic schools with athletic programs to include a cardiovascular prescreening as part of the standard physical examination for students participating in interscholastic sports, starting in the 2026-2027 school year. This prescreening - based on family history, personal symptoms, and evidence-based guidelines - must be conducted no earlier than 90 days before the school year begins. If a positive finding occurs, healthcare providers must refer students to a cardiologist for further evaluation. Schools must report annual data on screenings and referrals to county health departments, with the Maryland Department of Health publishing public reports analyzing outcomes. The bill directly affects student athletes, schools, and healthcare providers conducting sports physicals.
Showing 91 to 100 of 109 bills